Alzheimer
-
ADDF to invest $2 m to boost search for digital biomarkers for early Alzheimer’s
Aims to develop a digital Toolkit of apps and wearables to detect the very earliest stage of Alzheimer’s The Alzheimer’s…
Read More » -
Lilly Alzheimer’s drug shows benefit on cognition, function in mid-stage trial
The drug, Donanemab showed positive trends that failed to reach statistical significance on a range of secondary trial goals Eli…
Read More »